Avalo Therapeutics, Inc. (AVTX)
13.65
+0.22
(+1.64%)
USD |
NASDAQ |
Oct 09, 16:00
13.65
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Price : 13.65 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 13.42 | 13.82 | 13.36 | 13.65 | 648582.0 |
| Oct 08, 2026 | 13.45 | 13.60 | 12.77 | 13.43 | 990405.0 |
| Oct 07, 2026 | 13.43 | 13.98 | 13.30 | 13.58 | 719025.0 |
| Oct 06, 2026 | 14.58 | 14.58 | 13.23 | 13.59 | 955580.0 |
| Oct 05, 2026 | 15.09 | 15.09 | 14.39 | 14.60 | 736839.0 |
| Oct 02, 2026 | 15.05 | 15.16 | 14.31 | 14.99 | 948519.0 |
| Oct 01, 2026 | 15.24 | 15.57 | 14.78 | 14.95 | 932392.0 |
| Sep 30, 2026 | 15.80 | 15.99 | 15.14 | 15.33 | 1.433M |
| Sep 29, 2026 | 15.16 | 15.67 | 14.74 | 15.58 | 1.332M |
| Sep 28, 2026 | 15.47 | 15.47 | 14.97 | 15.08 | 749653.0 |
| Sep 25, 2026 | 15.75 | 15.81 | 15.00 | 15.47 | 1.434M |
| Sep 24, 2026 | 15.24 | 16.10 | 14.58 | 15.72 | 1.897M |
| Sep 23, 2026 | 16.40 | 16.49 | 15.13 | 15.30 | 1.111M |
| Sep 22, 2026 | 16.44 | 16.86 | 16.28 | 16.51 | 585526.0 |
| Sep 21, 2026 | 16.57 | 16.75 | 15.92 | 16.17 | 542683.0 |
| Sep 18, 2026 | 16.66 | 16.92 | 16.34 | 16.57 | 3.233M |
| Sep 17, 2026 | 17.10 | 17.19 | 16.52 | 16.69 | 691275.0 |
| Sep 16, 2026 | 16.17 | 16.70 | 15.87 | 16.58 | 1.445M |
| Sep 15, 2026 | 16.13 | 16.69 | 15.39 | 16.07 | 1.103M |
| Sep 14, 2026 | 16.43 | 16.53 | 16.12 | 16.18 | 908424.0 |
| Sep 11, 2026 | 17.42 | 18.14 | 16.02 | 16.12 | 2.525M |
| Sep 10, 2026 | 17.92 | 18.05 | 17.15 | 17.18 | 913754.0 |
| Sep 09, 2026 | 19.47 | 19.74 | 18.04 | 18.21 | 725724.0 |
| Sep 08, 2026 | 19.01 | 20.49 | 18.95 | 19.71 | 779695.0 |
| Sep 04, 2026 | 18.81 | 19.62 | 18.79 | 19.23 | 633231.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 276.47 |
| Rezolute, Inc. | 4.87 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.68 |
| Anika Therapeutics, Inc. | 19.58 |
Price Related Metrics
| PS Ratio | 5565.39 |
| Price to Book Value | 1.609 |
| Earnings Yield | -34.72% |
| Market Cap | 722.09M |